Cc1nc(C(=O)N2CCCC(C(=O)c3cccc(OC(C)C)c3)C2)cs1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?